Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,631,948
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
24,555,195
-
Shares change
-
+7,228,194
-
Total reported value, excl. options
-
$222,707,000
-
Value change
-
+$65,545,435
-
Number of buys
-
16
-
Number of sells
-
-8
-
Price
-
$9.10
Significant Holders of Vigil Neuroscience, Inc. - Common Stock (VIGL) as of Q3 2022
35 filings reported holding VIGL - Vigil Neuroscience, Inc. - Common Stock as of Q3 2022.
Vigil Neuroscience, Inc. - Common Stock (VIGL) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24,555,195 shares
of 46,631,948 outstanding shares and own 53% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (5,836,874 shares), Northpond Ventures, LLC (4,214,498 shares), Deep Track Capital, LP (2,363,188 shares), Artal Group S.A. (2,285,574 shares), CITADEL ADVISORS LLC (2,166,467 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2,054,794 shares), BVF INC/IL (1,813,633 shares), Cormorant Asset Management, LP (616,786 shares), Pivotal bioVenture Partners Investment Advisor LLC (560,595 shares), and Rock Springs Capital Management LP (471,958 shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.